Fiche publication
Date publication
décembre 2025
Journal
Archives of virology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PRETET Jean-Luc
Tous les auteurs :
Di Domizio N, Debernardi A, Olivier M, Bôle-Richard E, Caël B, Gaillot S, Prétet JL, Lepiller Q
Lien Pubmed
Résumé
Human papillomavirus (HPV) 16 variants can differ in their oncogenic potential. Here, we investigated the effect of the amino acid substitutions H78Y and L83V in the E6 oncoprotein of HPV16 on early immune escape and p53 degradation in vitro. Although E6 inhibits the RIG-I-IRF-3-IFN-β pathway, this inhibition was not affected by the H78Y substitution. We found that the L83V mutation did not significantly affect p53 and p21 expression, cell migration and proliferation, or resistance to apoptosis. We therefore conclude that the H78Y and L83V substitutions in E6 had no phenotypic effect on early immune escape and p53 degradation, respectively, in our model.
Mots clés
Carcinogenesis, E6 oncoprotein, HPV16, Immune escape
Référence
Arch Virol. 2025 12 18;171(1):25